Albendazole Market - Global Professional Analysis and Forecast to 2026

Dec 25, 2019  |  222 PAGES  |  REPORT CODE: CMM257838
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Albendazole market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.

This report presents the market size and development trends by detailing the Albendazole market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Albendazole market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Albendazole industry and will help you to build a panoramic view of the industrial development.

Albendazole Market, By Type:

  • Capsule

  • Tablet

Albendazole Market, By Application:

  • Pinworm Infection Treatment

  • Ascaris Infection Treatment

  • Other Parasitic Infections Treatment

Some of the leading players are as follows:

  • Fredun Pharmaceuticals Ltd

  • Leo Bio-Care Pvt.

  • Supharma Chem

  • K.A.Malle Pharmaceuticals

  • Sequent Scientifi

  • CHANGZHOU YABANG

  • Lasa Laboratory Pvt Ltd

  • Salius Pharma

  • Hubei Zhongjia-chem Pharmaceutical

  • HUBEI KEYI

  • Huazhong Pharmaceutical

  • MANAV DRUGS

  • AdvacarePharma

  • GlaxoSmithKline

  • Ashish life Science Pvt. Ltd.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Albendazole Market: Technology Type Analysis

  • 4.1 Albendazole Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Albendazole Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Capsule

    • 4.3.2 Tablet

5 Albendazole Market: Product Analysis

  • 5.1 Albendazole Product Market Share Analysis, 2018 & 2026

  • 5.2 Albendazole Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Albendazole Market: Application Analysis

  • 6.1 Albendazole Application Market Share Analysis, 2018 & 2026

  • 6.2 Albendazole Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Pinworm Infection Treatment

    • 6.3.2 Ascaris Infection Treatment

    • 6.3.3 Other Parasitic Infections Treatment

7 Albendazole Market: Regional Analysis

  • 7.1 Albendazole Regional Market Share Analysis, 2018 & 2026

  • 7.2 Albendazole Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Fredun Pharmaceuticals Ltd

    • 9.1.1 Fredun Pharmaceuticals Ltd Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Leo Bio-Care Pvt.

    • 9.2.1 Leo Bio-Care Pvt. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Supharma Chem

    • 9.3.1 Supharma Chem Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 K.A.Malle Pharmaceuticals

    • 9.4.1 K.A.Malle Pharmaceuticals Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Sequent Scientifi

    • 9.5.1 Sequent Scientifi Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 CHANGZHOU YABANG

    • 9.6.1 CHANGZHOU YABANG Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Lasa Laboratory Pvt Ltd

    • 9.7.1 Lasa Laboratory Pvt Ltd Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Salius Pharma

    • 9.8.1 Salius Pharma Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Hubei Zhongjia-chem Pharmaceutical

    • 9.9.1 Hubei Zhongjia-chem Pharmaceutical Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 HUBEI KEYI

    • 9.10.1 HUBEI KEYI Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Huazhong Pharmaceutical

    • 9.11.1 Huazhong Pharmaceutical Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 MANAV DRUGS

    • 9.12.1 MANAV DRUGS Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 AdvacarePharma

    • 9.13.1 AdvacarePharma Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 GlaxoSmithKline

    • 9.14.1 GlaxoSmithKline Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Ashish life Science Pvt. Ltd.

    • 9.15.1 Ashish life Science Pvt. Ltd. Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 97 Figures and 145 Tables)

  • Figure Capsule Albendazole market, 2015 - 2026 (USD Million)

  • Figure Tablet Albendazole market, 2015 - 2026 (USD Million)

  • Figure Pinworm Infection Treatment market, 2015 - 2026 (USD Million)

  • Figure Ascaris Infection Treatment market, 2015 - 2026 (USD Million)

  • Figure Other Parasitic Infections Treatment market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Albendazole market, by country, 2015 - 2026 (USD Million)

  • Table North America Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table North America Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table North America Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Canada Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Canada Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Europe Albendazole market, by country, 2015 - 2026 (USD Million)

  • Table Europe Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Europe Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Europe Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Germany Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Germany Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table France Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table France Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Italy Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Italy Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Spain Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Spain Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Albendazole market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table China Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table China Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Japan Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Japan Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table India Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table India Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Albendazole market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table MEA Albendazole market, by country, 2015 - 2026 (USD Million)

  • Table MEA Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table MEA Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table MEA Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Albendazole market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Albendazole market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Albendazole market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Fredun Pharmaceuticals Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Leo Bio-Care Pvt. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Supharma Chem Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table K.A.Malle Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sequent Scientifi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CHANGZHOU YABANG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lasa Laboratory Pvt Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Salius Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hubei Zhongjia-chem Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table HUBEI KEYI Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Huazhong Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MANAV DRUGS Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AdvacarePharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ashish life Science Pvt. Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top